Top 10 famrz.de Competitors

arbrb.de

Das BMAS hat am 28.9.2022 inhaltlich nicht wirklich überraschende FAQ's zur Arbeitszeiterfassung nach BAG, Beschluss vom 13. September 2022 – 1 ABR 22/21, ArbRB 2022, 299 (Braun) veröffentlicht. Jeder mag bewerten, ob er die Ansichten teilt.

kanzlei-hasselbach.de

die kanzlei hasselbach mit büros in köln, bonn und frankfurt am main bietet kompetente beratung im familien- und arbeitsrecht.

schmerzensgeld-spezialisten.de

spezialisten für schmerzensgeld + schadensersatz nur für geschädigte patienten und unfallopfer! kostenlose + unverbindliche ersteinschätzung jetzt anfragen!

consortium-psy.com

Consortium PSYCHIATRICUM Vol 1, No 1 (2020)

skvshop.de

ihr online-shop für fachpublikationen, arbeitsmaterialien und fachzeitschriften aus ergotherapie, logopädie, sprachtherapie, physiotherapie und pflegefamilie/adoption.

archivesofrheumatology.org

Background/Aims: The primary objective of this investigation is to systematically assess the resemblances and distinctions between enthesitisrelated arthritis (ERA), which serves as a pediatric analog to ankylosing spondylitis (AS), and AS. Materials and Methods: A cross-sectional analysis was conducted within a pediatric rheumatology facility and an adult rheumatology institution. Demographic and clinical attributes were juxtaposed between individuals diagnosed with AS and those with ERA. Results: A cumulative total of 200 subjects (101 minors, 99 adults) were scrutinized. The prevalence of peripheral arthritis was significantly elevated in ERA (54.5%) compared to AS (21.2%, P < .001), whereas sacroiliitis, axial involvement, and morning stiffness were more prevalent in AS. Nonsteroidal anti-inflammatory drugs constituted the predominant initial therapeutic approach (99% vs. 91.9%, P = .01). Patients with ERA exhibited a higher utilization of corticosteroids (35.6% vs. 11.1%, P < .001) and diseasemodifying antirheumatic drugs (DMARDs) (87.1% vs. 60.6%, P < .001), with no notable variance in the application of biological agents. At the final follow-up assessment, 24.8% of ERA patients were free from medication, whereas no AS patients achieved a medication-free status. Conclusion: An increased volume of scientific evidence is requisite concerning the attributes of ERA, which is presently regarded predominantly within the framework of juvenile spondyloarthritis, distinguishing it from its adult counterpart; this study serves as an observational cohort investigation that underscores this imperative. Despite the observable differences and similarities between ERA and AS, further extensive studies incorporating inflammatory biomarkers are essential to ascertain whether these conditions represent discrete diseases or exist within a broader disease continuum. Cite this article as: Unan MK, Özaslan Z, Dilek G, Şahin N, Sönmez HE, Nas K. Juvenile vs. adult-onset spondylo

reusz.eu

prof. dr. philipp m. reuß, mjur(oxon.) institut für privat- und prozessrecht | universität göttingen